Skip to main content
Caplight Logo









Rebel Medicine

Rebel Medicine

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.rebelmedicine.com/

Last Round

Series A

Jun 4, 2026

Total Funding Raised

$11.16M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rebel Medicine is a biotechnology company that develops non-opioid pharmaceutical products for acute and post-operative pain management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

non-opioid pain managementextended-release anestheticspostoperative analgesiadrug delivery technologypain managementopioid-sparingbiotechnologylocal anestheticdrug-releasing dressingclinical-stage biotechinvestigational new drugINDnew drug applicationNDAnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rebel Medicine Comparables

Compare Rebel Medicine with similar companies based on industry and business-model similarity.

Rebel Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Concentric Analgesic
88%
Allay Therapeutics
84%
Virpax Pharmaceuticals Inc
84%

Rebel Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 4, 2026
Series AJun 12, 2025
SeedFeb 6, 2025
GrantSep 1, 2020

Key People

Founding team and executive leadership

Caleb Lade

Co-Founder, COO

Founding Team

Rebel Medicine Investors

Notable investors and investment history

Rebel Medicine investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
Utah Innovation FundSeries A
Central Texas Angel NetworkSeries A, Seed
S.K. Hart ManagementSeries A
Crocker VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 45% MoM, reaching 1.8K.

  • Jun 4, 2026

    $9M raised in Seed Round.

Rebel Medicine Filings

Explore SEC and related filing metadata, where available.

Rebel Medicine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rebel Medicine's valuation, stock price, and market status.

Is Rebel Medicine a public or private company?

Rebel Medicine is a private company.

What is the current stock price of Rebel Medicine?

Rebel Medicine is a private company with no public stock price. No recent secondary market data is available.

How much is Rebel Medicine worth (valuation)?

Valuation information for Rebel Medicine is not publicly available.

Can I buy Rebel Medicine stock?

Rebel Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rebel Medicine's last funding round?

Rebel Medicine's most recent funding round was Series A on June 4, 2026.

Who are the main investors in Rebel Medicine?

Key investors in Rebel Medicine include Central Texas Angel Network, Crocker Ventures.

Will Rebel Medicine IPO soon?

No public IPO plans have been announced for Rebel Medicine.

How can I track Rebel Medicine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rebel Medicine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range11
Year Founded2020
Last FundingJun 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?